Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions

International Journal of Obesity

Volumn 35, Issue 5, 2011, Pages 629-641

  De Backer, M W A ^a   La Fleur, S E ^a,b   Brans, M A D ^a   Van Rozen, A J ^a   Luijendijk, M C M ^a   Merkestein, M ^a   Garner, K M ^a   Van Der Zwaal, E M ^a   Adan, R A H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

AgRP; hypothalamus; meal size; melanocortin receptors; rAAV

Indexed keywords

AGOUTI RELATED PROTEIN; INSULIN; LEPTIN; MELANOCORTIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; PARVOVIRUS VECTOR; PROOPIOMELANOCORTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CORE TEMPERATURE; FOOD INTAKE; GENE EXPRESSION; GENE OVEREXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; INSULIN BLOOD LEVEL; LATERAL HYPOTHALAMUS; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ZONA INCERTA;

AGOUTI-RELATED PROTEIN; ANIMALS; BODY WEIGHT; CELL LINE; EATING; ENERGY METABOLISM; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMUS; MALE; MIDLINE THALAMIC NUCLEI; NUCLEUS ACCUMBENS; OBESITY; RATS; RATS, WISTAR; RECEPTORS, MELANOCORTIN; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

AGOUTI; RATTUS;

EID: 79955848124     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.169     Document Type: Article

References (60)

1. Nijenhuis WA, Oosterom J, Adan RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 2001; 15: 164-171. (Pubitemid 32156049)
2. Haskell-Luevano C, Monck EK. Agouti-related protein functions as an inverse agonist at a constitutively active brain melano-cortin-4 receptor. Regul Pept 2001; 99: 1-7. (Pubitemid 32232121)
3. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Over-expression of Agrt leads to obesity in transgenic mice. Nat Genet 1997; 17: 273-274.
4. Small CJ, Liu YL, Stanley SA, Connoley IP, Kennedy A, Stock MJ et al. Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes Relat Metab Disord 2003; 27: 530-533. (Pubitemid 36520854)
5. Semjonous NM, Smith KL, Parkinson JR, Gunner DJ, Liu YL, Murphy KG et al. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuro-peptides involved in energy balance. Int J Obes (Lond) 2009; 33: 775-785.
6. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138. (Pubitemid 27446294)
7. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 1995; 92: 4728-4732.
8. Kas MJ, Tiesjema B, Van Dijk G, Garner KM, Barsh GS, ter Brake O et al. Induction of brain-region-specific forms of obesity by agouti. J Neurosci 2004; 24: 10176-10181. (Pubitemid 39492043)
9. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141. (Pubitemid 27180337)
10. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 2000; 9: 145-154. (Pubitemid 30610232)
11. Ste ML, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000; 97: 12339-12344.
12. Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD. Melanocortin-4 receptor is required for acute homeo-static responses to increased dietary fat. Nat Neurosci 2001; 4: 605-611. (Pubitemid 32507374)
13. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97-102.
14. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 3518-3521. (Pubitemid 32269044)
15. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 2003; 457: 213-235. (Pubitemid 36158283)
16. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM et al. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 2003; 23: 7143-7154. (Pubitemid 36975878)
17. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993; 90: 8856-8860. (Pubitemid 23306409)
18. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ et al. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 2000; 49: 177-182. (Pubitemid 30070994)
19. Shrestha YB, Wickwire K, Giraudo SQ. Role of AgRP on Ghrelin-induced feeding in the hypothalamic paraventricular nucleus. Regul Pept 2006; 133: 68-73. (Pubitemid 41820338)
20. Wirth MM, Giraudo SQ. Agouti-related protein in the hypotha-lamic paraventricular nucleus: effect on feeding. Peptides 2000; 21: 1369-1375.
21. Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 2002; 26: 393-428.
22. Tiesjema B, Adan RA, Luijendijk MC, Kalsbeek A, la Fleur SE. Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior. J Neurosci 2007; 27: 14139-14146. (Pubitemid 351377878)
23. Tiesjema B, la Fleur SE, Luijendijk MC, Brans MA, Lin EJ, During MJ et al. Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obesity (Silver Spring) 2007; 15: 2424-2435. (Pubitemid 350034036)
24. Broekman MLD, Comer LA, Hyman BT, Siena-Esteves M. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or-2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 2006; 138: 501-510. (Pubitemid 43255560)
25. Grimm D, Kay MA, Kleinschmidt JA. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 2003; 7: 839-850. (Pubitemid 36790261)
26. de Backer M, Brans M, Luijendijk M, Garner K, Adan R. Optimization of adeno-associated viral vector mediated gene delivery to the hypothalamus. Hum Gene Ther 2010; 21: 673-682.
27. Schaeren-Wiemers N, Gerfin-Moser A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 1993; 100: 431-440. (Pubitemid 24049312)
28. Kas MJH, Van Dijk G, Scheurink AJW, Adan RAH. Agouti-related protein prevents self-starvation. Mol Psychiatry 2003; 8: 235-240. (Pubitemid 36315233)
29. la Fleur SE, Van Rozen AJ, Luijendijk MC, Groeneweg F, Adan RA. A free-choice high-fat high-sugar diet induces changes in arcuate neuropeptide expression that support hyperphagia. Int J Obes (Lond) 2009; 34: 537-546.
30. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532. (Pubitemid 126508820)
31. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227-3234. (Pubitemid 26121941)
32. Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. Mol Ther 2007; 15: 1504-1511. (Pubitemid 47103062)
33. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005; 123: 493-505. (Pubitemid 41546678)
34. Kask A, Schioth HB. Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Res 2000; 887: 460-464. (Pubitemid 32008075)
35. Woods SC. The control of food intake: behavioral versus molecular perspectives. Cell Metab 2009; 9: 489-498.
36. Erlanson-Albertsson C. Appetite regulation and energy balance. Acta Paediatr 2005; 94: 40-41.
37. Tang-Christensen M, Vrang N, Ortmann S, Bidlingmaier M, Horvath TL, Tschop M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 2004; 145: 4645-4652. (Pubitemid 39281457)
38. Santollo J, Eckel LA. Estradiol decreases the orexigenic effect of neuropeptide Y, but not agouti-related protein, in ovariectomized rats. Behav Brain Res 2008; 191: 173-177.
39. Zheng H, Patterson LM, Phifer CB, Berthoud HR. Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am J Physiol Regul Integr Comp Physiol 2005; 289: R247-R258. (Pubitemid 40874981)
40. Azzara AV, Sokolnicki JP, Schwartz GJ. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiol Behav 2002; 77: 411-416. (Pubitemid 35373896)
41. Williams DL, Grill HJ, Weiss SM, Baird JP, Kaplan JM. Behavioral processes underlying the intake suppressive effects of melano-cortin 3/4 receptor activation in the rat. Psychopharmacology (Berl) 2002; 161: 47-53. (Pubitemid 34437968)
42. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095. (Pubitemid 36337319)
43. Creemers JW, Pritchard LE, Gyte A, Le Rouzic P, Meulemans S, Wardlaw SL et al. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology 2006; 147: 1621-1631.
44. Skibicka KP, Grill HJ. Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins. Endocrinology 2009; 150: 5351-5361.
45. Wortley KE, Anderson KD, Yasenchak J, Murphy A, Valenzuela D, Diano S et al. Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab 2005; 2: 421-427.
46. Kreier F, Kap YS, Mettenleiter TC, Van Heijningen C, Van der Vliet J, Kalsbeek A et al. Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 2006; 147: 1140-1147. (Pubitemid 43244345)
47. Song CK, Jackson RM, Harris RB, Richard D, Bartness TJ. Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1467-R1476. (Pubitemid 41507413)
48. Song CK, Vaughan CH, Keen-Rhinehart E, Harris RB, Richard D, Bartness TJ. Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am J Physiol Regul Integr Comp Physiol 2008; 295: R417-R428.
49. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melano-cortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperlepti-nemia. Hypertension 2005; 46: 326-332. (Pubitemid 41099165)
50. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52.
51. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007; 117: 3475-3488. (Pubitemid 350097003)
52. Arase K, Sakaguchi T, Bray GA. Lateral hypothalamic lesions and activity of the sympathetic nervous system. Life Sci 1987; 41: 657-662. (Pubitemid 17097821)
53. Yoshida T, Kemnitz JW, Bray GA. Lateral hypothalamic lesions and norepinephrine turnover in rats. J Clin Invest 1983; 72: 919-927. (Pubitemid 14211402)
54. Sakaguchi T, Arase K, Bray GA. Sympathetic activity and food intake of rats with ventromedial hypothalamic lesions. Int J Obes 1988; 12: 285-291.
55. Takahashi A, Shimazu T. Hypothalamic regulation of lipid metabolism in the rat: effect of hypothalamic stimulation on lipolysis. J Auton Nerv Syst 1981; 4: 195-205. (Pubitemid 11025428)
56. Zhong MK, Duan YC, Chen AD, Xu B, Gao XY, De W et al. Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol 2008; 93: 746-753. (Pubitemid 351678597)
57. Gettys TW, Harkness PJ, Watson PM. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137: 4054-4057. (Pubitemid 26284684)
58. Cong L, Chen K, Li J, Gao P, Li Q, Mi S et al. Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochem J 2007; 403: 519-525. (Pubitemid 46706980)
59. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H et al. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 2005; 482: 217-243. (Pubitemid 40066639)
60. Tiesjema B, la Fleur SE, Luijendijk MC, Adan RA. Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity (Silver Spring) 2009; 17: 1448-1450.